The market is propelled forward by an increase in federal funding for stem cell therapy. Here are five key vendors.
1. Holostem Advanced Therapies
2. JCR Pharmaceuticals
3. Organogenesis
4. Osiris Therapeutics
5. Vericel
More articles on biologics:
Cerapedics receives FDA IDE approval for study of P-15L Bone Graft in TLIF surgery: 4 things to know
4 things to know about mensenchymal stromal cells in spine
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
